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Previews
ering from flow, a property normally restricted to selec-A Supercode for Inflammation
tin-glycoprotein interactions and functionally similar in-
teractions like CD44 with proteoglycan (Alon et al.,
1995). It is well established that the low-affinity form of
Siegelman and colleagues demonstrate unexpected LFA-1 can alter the dynamics of rolling adhesion through
synergism of CD44 and VLA-4 during lymphocyte ex- transient interactions with ICAMs (Kunkel et al., 1996;
travasation. This is the first time that molecules medi- Salas et al., 2002), but VLA-4 was the only integrin
ating rolling and firm adhesion have been shown to claimed to be efficient at the initial tethering step. In
associate biochemically leading to direct functional retrospect, it is now possible that many experiments
cooperation. that demonstrated VLA-4-mediated tethering to cellular
substrates, particularly activated endothelial cells, may
Three digit telephone “area codes” are a useful met- have been based on VLA-4’s close functional associa-
aphor for immune cell homing, helping organize the tion with CD44 and the expression of proteoglycan li-
numerous receptor-ligand pairs that mediate three dis- gands for CD44 on endothelial cells along with VCAM-1.
crete steps of tethering by lectin-glycoprotein interac- However, experiments with purified VCAM-1 by Alon
tions, activation by G protein-coupled receptors, and et al. argue for the capacity of direct VLA-4-VCAM-1
firm adhesion by integrins that are needed to initiate interactions in tethering from flow (Alon et al., 1995).
extravasation (Springer, 1994). The area code metaphor Regardless, it will be important to test anti-CD44 anti-
has worked because the individual “digits” have been bodies in these assays since ligands for CD44 could
seen as independent, and therefore, all three-way com- contaminate human serum albumen preparations used
binations of selectin-glycoprotein, GPCR-attractant, for blocking or even be directly carried by highly glycosy-
and integrin-ligand pairs would be expected to work lated VCAM-1 molecules, allowing a cryptic contribution
similarly for mediating attachment and extravasation. A of CD44 to the integrin-mediated tethering.
study in this volume of Immunity from Siegelman and The physical basis for this special synergism between
colleagues demonstrates for the first time that specific CD44 and VLA-4 may be that firm adhesion sites can
pairwise combinations can be much better than others be directly nucleated from the transient tethering sites
due to the molecular organization of the receptors on when VLA-4 is preconcentrated with CD44. The specific
the cell surface, creating a supercode (Nandi et al., 2004 molecules that link the cytoplasmic domain of CD44 to
[this issue of Immunity]). VLA-4 were not identified specifically, but a number of
The study focuses on the tethering molecule CD44, candidates were coprecipitated with CD44 and VLA-4.
which was originally linked to lymphocyte homing by The study does not address the GPCR-mediated activa-
Butcher and colleagues (Jalkanen et al., 1987). CD44 is tion step, which was replaced by phorbol ester-stimu-
induced on effector and memory T lymphocytes and lated activation in the in vitro experiments. The in vivo
metastatic tumors and has a C type lectin-like N-terminal studies demonstrate that either a triggering step is not
domain that binds the proteoglycan hyaluronic acid on needed by this unique combination, or it is provided
the surface of activated endothelial cells (Aruffo et al., by endogenous signals, perhaps specific GPCR-ligand
1990). CD44 can act in a “selectin-like” manner, mediat- interactions, at inflamed sites in vivo. If it is correct
ing rapid but transient attachment of cells that are rap- that the advantage of this configuration stems from the
idly flowing over the endothelial surface (DeGrendele ability to directly mature tethering sites into firm adhe-
et al., 1996). Earlier work from Siegelman’s group had sion sites then it would also make sense to locate the
suggested a special relationship between CD44 and activation mechanism in the same complex. It will be
very late activation antigen-4 (VLA-4), an integrin that interesting to see if this prediction is correct or if it is
binds vascular cell adhesion molecule-1 (VCAM-1) also sufficient to preconfigure the tethering and firm adhe-
expressed on activated endothelial cells, but there had sion steps to achieve this synergism. The results have
been no explanation for this apparent partnership from implications for both effector T cell entry into inflamed
which other integrins, like lymphocyte function associ- sites and tumor metastasis where coexpression of CD44
ated-1 (LFA-1), were excluded (Siegelman et al., 2000). and VLA-4 (an integrin that is expressed on nonhemato-
In the current work they have discovered that CD44 can poietic cells also) may be reexamined with great interest
be coimmunoprecipitated with VLA-4 but not LFA-1 and (Gilcrease et al., 1996).
that the association between CD44 and VLA-4 requires
the cytoplasmic domain of CD44. Furthermore, CD44
lacking the cytoplasmic domain is unable to synergize
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peptides both in the cytosol/nucleus (where protea-Proteasomes Get By with
somes are located) and in the endoplasmic reticulumLots of Help from Their Friends (ER), following delivery of peptides by the transporter
associated with antigen processing (TAP). ER amino-
peptidases appear to play a particularly important role
in peptide generation (Serwold et al., 2002; York et al.,Proteasomes can’t do it all. It was previously known
2002).that aminopeptidases frequently degrade protea-
For obscure, but no doubt important, reasons cellssome-generated peptides. Now it appears that an-
are devoid of active carboxypeptidases. It has been
other protease, tripeptidyl peptidase II (TPP II), plays
generally accepted that proteasomes must liberate the
a critical role in cleaving proteasomal produced pep-
C termini of class I peptide ligands (Shastri et al., 2002).
tides into shorter peptides that can then be degraded
With the findings of Reits et al., published in this issue
by aminopeptidases.
of Immunity, it now appears that a second large cellular
protease with endopeptidase activity contributes to the
Nature abounds with nasty, selfish things like viruses generation of C-terminal cleavages that produce MHC
and tumor cells bent on their own survival at our ex- class I binding peptides. Most importantly, the authors
pense. Fortunately, for protection our vertebrate ances- provide convincing evidence that this protease, tripepti-
tors endowed us with CD8 T cells and MHC class I dyl peptidase II (TPP II), plays an essential role in gener-
molecules (and NK cells, etc.). CD8 T cells roam our ating many MHC class I peptide ligands.
nooks and crannies, sifting through countless MHC The participation of TPP II in antigen presentation was
class I molecules for the faintest peptidic traces of trou- first implied by the findings of Glas et al. (1998), who
ble. Unless a cell happens to be a professional antigen- reported that a large protease (later identified as TPP II
presenting cell, nearly all of the peptides displayed by by Geier et al. [1999]) could replace the functions of
class I molecules will have been synthesized by the proteasomes in cells adapted to grow in the proteasome
cell’s own ribosomes. Virtually all of these peptides are inhibitor NLVS. Subsequently, however, it was shown
generated from longer polypeptides by the action of that NLVS-resistant cells remained sensitive to all other
proteases. Current evidence suggests that most of pep- proteasome inhibitors tested, raising doubts regarding
tides are derived from the significant fraction of polypep- the functional overlap between TPP II and proteasomes
tides degraded with a half-life of10 min following their (Princiotta et al., 2001). In any event, Geier et al. demon-
synthesis (Yewdell et al., 2003). Presumably these pro- strated that TPP II exhibits endopeptidase activity, sug-
teins are degraded due to some defect that prevents gesting the possibility that it contributes to the many
them from attaining a stable conformation in a reason- independent examples of ongoing antigen presentation
able time frame. in proteasome inhibitor treated cells (Shastri et al., 2002).
This year marks the tenth anniversary of the landmark The proverbial smoking gun was provided by Seifert et
study demonstrating that proteasomes are responsible al. (2003), in demonstrating that generation of a defined
for the vast majority of protein degradation in cells (in- viral peptide required catalytically active TPP II but
cluding degradation of newly synthesized proteins), and not proteasomes.
are involved in the generation of most class I peptide In their present study, Reits et al. place TPP II squarely
ligands (Rock et al., 1994). Class I molecules are finicky in the main stream of class I processing pathways. This
about peptide length; each peptide presented has an group has pioneered the (in their own words) “single
optimal length for high- affinity binding that ranges from cell biochemistry” approach to antigen processing by
8 to 11 residues. It was initially thought that proteasomes creative application of fluorescent molecules and confo-
acted as a “molecular ruler,” generating peptides of cal microscopy. In this installment, they use internally
the proper length for high-affinity class I binding. More quenched fluorescent peptides microinjected into cells
recent studies, however, demonstrated that this was to characterize peptide degradation, which is inferred
the exception rather than the rule(r). Most proteasome- by increased fluorescence that accompanies cleavage
generated peptides require further trimming. It is now between the fluorescent and quencher groups attached
to amino acid side chains. This is an exquisite applica-clear that aminopeptidases trim proteasome- generated
